Regulation of T Cell Differentiation and Function by EZH2
Theodoros Karantanos(Johns Hopkins University), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Anthos Chistofides(Beth Israel Deaconess Medical Center), Kankana Barhdan(Beth Israel Deaconess Medical Center), Le‐Qun Li(Beth Israel Deaconess Medical Center)
Cited by 81
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k